STOCK TITAN

[8-K] Pacific Premier Bancorp Inc Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

La Rosa Holdings Corp. (LRHC) has distributed a Preliminary Information Statement (Schedule 14C) announcing that stockholders holding approximately 97.2 % of voting power—principally CEO Joseph La Rosa via common stock and Series X Super Voting Preferred Stock—have delivered written consent to approve two key corporate actions:

  • Issuance of “New Conversion Shares” above Nasdaq’s 19.99 % threshold. The consent satisfies Nasdaq Listing Rules 5635(b) and 5635(d) in connection with the June 18 2025 Exchange Agreement under which the Company swapped Incremental Warrants for 6,000 shares of Series B Convertible Preferred Stock. These preferred shares convert at the lesser of a fixed $0.25 price or a variable “Alternate Conversion Price” (floor $0.082 and 95 % of the 7-day VWAP), subject to a 4.99 % ownership cap per holder. The note principal associated with the earlier financing is $5.5 million; full conversion could exceed the 20 % issuance limit, hence the need for approval.
  • Adoption of the Second Amended & Restated 2022 Equity Incentive Plan. The share pool rises from 156,250 (post 80-for-1 reverse split) to 374,961 shares, and the definition of “Consultant” is broadened to include wholly-owned legal entities of individuals.

The actions become effective 20 days after mailing. No meeting or proxy is required. Minority holders have no dissenter or appraisal rights.

Investor implications:

  • The approval maintains Nasdaq listing compliance and unlocks the capital structure needed to convert the Series B Preferred Stock and potentially reduce debt.
  • However, the variable-priced conversion and enlarged incentive plan introduce significant dilution risk for existing common shareholders.
  • Control remains highly concentrated: 2,000 Series X shares carry 20 million votes (10,000 votes each), giving the CEO effective control over future corporate decisions.

La Rosa Holdings Corp. (LRHC) ha distribuito una Dichiarazione Informativa Preliminare (Schedule 14C) annunciando che gli azionisti detentori di circa il 97,2% del potere di voto—principalmente il CEO Joseph La Rosa tramite azioni ordinarie e azioni privilegiate Serie X con super voto—hanno fornito il consenso scritto per approvare due importanti azioni societarie:

  • Emissione di “Nuove Azioni di Conversione” oltre la soglia del 19,99% stabilita da Nasdaq. Il consenso soddisfa le regole di quotazione Nasdaq 5635(b) e 5635(d) in relazione all’Accordo di Scambio del 18 giugno 2025, con cui la Società ha scambiato Warrants Incrementali per 6.000 azioni di azioni privilegiate convertibili Serie B. Queste azioni privilegiate si convertono al prezzo minore tra un fisso di $0,25 o un “Prezzo di Conversione Alternativo” variabile (minimo $0,082 e il 95% della media ponderata dei prezzi degli ultimi 7 giorni), con un limite di possesso del 4,99% per singolo azionista. Il capitale del prestito associato al finanziamento precedente è di $5,5 milioni; la conversione completa potrebbe superare il limite del 20% di emissione, da qui la necessità dell’approvazione.
  • Adozione del Secondo Piano Incentivi Azionari Modificato e Rifirmato 2022. Il numero di azioni disponibili aumenta da 156.250 (dopo il raggruppamento azionario 80-per-1) a 374.961 azioni, e la definizione di “Consulente” viene estesa per includere entità legali interamente controllate da individui.

Le azioni diventeranno efficaci 20 giorni dopo la spedizione. Non è richiesta alcuna assemblea né delega. Gli azionisti di minoranza non hanno diritti di dissenso o di valutazione.

Implicazioni per gli investitori:

  • L’approvazione mantiene la conformità alla quotazione Nasdaq e sblocca la struttura di capitale necessaria per convertire le azioni privilegiate Serie B e potenzialmente ridurre il debito.
  • Tuttavia, la conversione a prezzo variabile e il piano incentivi ampliato introducono un significativo rischio di diluizione per gli azionisti ordinari esistenti.
  • Il controllo rimane fortemente concentrato: 2.000 azioni Serie X portano 20 milioni di voti (10.000 voti ciascuna), conferendo al CEO il controllo effettivo sulle decisioni aziendali future.

La Rosa Holdings Corp. (LRHC) ha distribuido una Declaración Informativa Preliminar (Schedule 14C) anunciando que los accionistas que poseen aproximadamente el 97,2% del poder de voto—principalmente el CEO Joseph La Rosa a través de acciones comunes y acciones preferentes Serie X con supervoto—han entregado su consentimiento por escrito para aprobar dos acciones corporativas clave:

  • Emisión de “Nuevas Acciones de Conversión” por encima del umbral del 19,99% establecido por Nasdaq. El consentimiento cumple con las reglas de cotización Nasdaq 5635(b) y 5635(d) en relación con el Acuerdo de Intercambio del 18 de junio de 2025, mediante el cual la Compañía intercambió Warrants Incrementales por 6,000 acciones de acciones preferentes convertibles Serie B. Estas acciones preferentes se convierten al menor entre un precio fijo de $0.25 o un “Precio de Conversión Alternativo” variable (mínimo $0.082 y 95% del VWAP de 7 días), sujeto a un límite de propiedad del 4,99% por titular. El principal del préstamo asociado al financiamiento anterior es de $5.5 millones; la conversión completa podría superar el límite de emisión del 20%, por lo que se requiere aprobación.
  • Adopción del Segundo Plan de Incentivos de Capital Modificado y Reformulado 2022. El grupo de acciones aumenta de 156,250 (después del split inverso 80 por 1) a 374,961 acciones, y la definición de “Consultor” se amplía para incluir entidades legales de propiedad total de individuos.

Las acciones entrarán en vigor 20 días después del envío. No se requiere reunión ni poder. Los accionistas minoritarios no tienen derechos de disenso o tasación.

Implicaciones para los inversores:

  • La aprobación mantiene el cumplimiento de la cotización en Nasdaq y desbloquea la estructura de capital necesaria para convertir las acciones preferentes Serie B y potencialmente reducir la deuda.
  • Sin embargo, la conversión a precio variable y el plan de incentivos ampliado introducen un riesgo significativo de dilución para los accionistas comunes existentes.
  • El control permanece altamente concentrado: 2,000 acciones Serie X otorgan 20 millones de votos (10,000 votos cada una), dando al CEO control efectivo sobre las decisiones corporativas futuras.

La Rosa Holdings Corp. (LRHC)는 예비 정보 성명서(Schedule 14C)를 배포하며 약 97.2%의 의결권을 보유한 주주들—주로 CEO Joseph La Rosa가 보통주와 Series X 슈퍼투표 우선주를 통해—가 두 가지 주요 기업 조치를 승인하는 서면 동의를 제출했다고 발표했습니다:

  • 나스닥의 19.99% 한도를 초과하는 “신규 전환 주식” 발행. 이 동의는 2025년 6월 18일 체결된 교환 계약과 관련하여 나스닥 상장 규칙 5635(b) 및 5635(d)를 충족합니다. 회사는 추가 워런트를 교환하여 6,000주의 Series B 전환 우선주를 받았습니다. 이 우선주는 고정 $0.25 가격 또는 변동 “대체 전환 가격”(최저 $0.082 및 7일 VWAP의 95%) 중 낮은 가격으로 전환되며, 보유자별 4.99% 소유 한도가 적용됩니다. 이전 자금 조달과 관련된 노트 원금은 $550만이며, 완전 전환 시 20% 발행 한도를 초과할 수 있어 승인이 필요합니다.
  • 2022년 2차 수정 및 재작성된 주식 인센티브 계획 채택. 주식 풀은 156,250주(80대 1 액면병합 후)에서 374,961주로 증가하며, “컨설턴트”의 정의가 개인이 전액 소유한 법인까지 확대됩니다.

이 조치들은 발송 후 20일 뒤에 효력이 발생합니다. 주주총회나 위임장은 필요 없습니다. 소수 주주는 반대권이나 감정권이 없습니다.

투자자에 대한 영향:

  • 이번 승인은 나스닥 상장 요건을 유지하고 Series B 우선주 전환과 부채 감축에 필요한 자본 구조를 확보합니다.
  • 그러나 변동 가격 전환과 확대된 인센티브 계획은 기존 보통주 주주에게 상당한 희석 위험을 초래합니다.
  • 지배권은 매우 집중되어 있습니다: 2,000주의 Series X 주식이 2,000만 표(주당 10,000표)를 보유하여 CEO가 향후 기업 결정에 대한 실질적인 통제권을 가집니다.

La Rosa Holdings Corp. (LRHC) a diffusé une déclaration d'information préliminaire (Schedule 14C) annonçant que des actionnaires détenant environ 97,2 % du pouvoir de vote—principalement le PDG Joseph La Rosa via des actions ordinaires et des actions privilégiées Série X avec super droit de vote—ont donné leur consentement écrit pour approuver deux actions clés :

  • Émission de « Nouvelles Actions de Conversion » dépassant le seuil Nasdaq de 19,99 %. Le consentement satisfait aux règles de cotation Nasdaq 5635(b) et 5635(d) en lien avec l’Accord d’Échange du 18 juin 2025, par lequel la société a échangé des bons de souscription supplémentaires contre 6 000 actions privilégiées convertibles de Série B. Ces actions privilégiées se convertissent au moindre entre un prix fixe de 0,25 $ ou un « Prix de Conversion Alternatif » variable (plancher à 0,082 $ et 95 % du VWAP sur 7 jours), avec un plafond de détention de 4,99 % par détenteur. Le principal de la dette liée au financement antérieur est de 5,5 millions de dollars ; une conversion complète pourrait dépasser la limite d’émission de 20 %, d’où la nécessité de l’approbation.
  • Adoption du Plan d’Incentives en Actions 2022, Deuxième Version Amendée et Reformulée. Le nombre d’actions disponibles passe de 156 250 (après un regroupement d’actions 80 pour 1) à 374 961 actions, et la définition de « Consultant » est élargie pour inclure les entités juridiques détenues à 100 % par des individus.

Les actions prennent effet 20 jours après envoi. Aucune assemblée ni procuration n’est requise. Les actionnaires minoritaires n’ont pas de droits de dissidence ou d’expertise.

Implications pour les investisseurs :

  • L’approbation maintient la conformité à la cotation Nasdaq et débloque la structure de capital nécessaire pour convertir les actions privilégiées de Série B et potentiellement réduire la dette.
  • Cependant, la conversion à prix variable et le plan d’incitation élargi introduisent un risque significatif de dilution pour les actionnaires ordinaires existants.
  • Le contrôle reste fortement concentré : 2 000 actions Série X représentent 20 millions de voix (10 000 voix chacune), donnant au PDG un contrôle effectif sur les décisions futures de l’entreprise.

La Rosa Holdings Corp. (LRHC) hat eine vorläufige Informationsmitteilung (Schedule 14C) verteilt, in der angekündigt wird, dass Aktionäre mit ungefähr 97,2 % der Stimmrechte—hauptsächlich CEO Joseph La Rosa über Stammaktien und Series X Super Voting Preferred Stock—schriftlich zugestimmt haben, zwei wichtige Unternehmensmaßnahmen zu genehmigen:

  • Ausgabe von „Neuen Umwandlungsaktien“ über die Nasdaq-Grenze von 19,99 % hinaus. Die Zustimmung erfüllt die Nasdaq-Listenregeln 5635(b) und 5635(d) im Zusammenhang mit der am 18. Juni 2025 geschlossenen Austauschvereinbarung, bei der das Unternehmen zusätzliche Warrants gegen 6.000 Aktien der Series B wandelbaren Vorzugsaktien getauscht hat. Diese Vorzugsaktien wandeln zum niedrigeren Wert von einem festen $0,25 oder einem variablen „Alternativen Umwandlungspreis“ (Mindestpreis $0,082 und 95 % des 7-Tage VWAP) um, mit einer Eigentumsobergrenze von 4,99 % pro Inhaber. Die Anleihekapitalhöhe der früheren Finanzierung beträgt $5,5 Millionen; eine vollständige Umwandlung könnte die 20 % Emissionsgrenze überschreiten, daher die Notwendigkeit der Zustimmung.
  • Verabschiedung des Zweiten Geänderten und Neufassungen des Aktienanreizplans 2022. Der Aktienpool steigt von 156.250 (nach einer 80-zu-1-Aktienzusammenlegung) auf 374.961 Aktien, und die Definition von „Berater“ wird erweitert, um vollständig im Besitz befindliche juristische Personen von Einzelpersonen einzuschließen.

Die Maßnahmen werden 20 Tage nach Versand wirksam. Es ist keine Versammlung oder Vollmacht erforderlich. Minderheitsaktionäre haben keine Widerspruchs- oder Bewertungsrechte.

Auswirkungen für Investoren:

  • Die Zustimmung sichert die Nasdaq-Listing-Compliance und ermöglicht die Kapitalstruktur, die für die Umwandlung der Series B Vorzugsaktien und potenzielle Schuldenreduzierung erforderlich ist.
  • Die variable Umwandlung und der erweiterte Anreizplan bringen jedoch ein erhebliches Verwässerungsrisiko für bestehende Stammaktionäre mit sich.
  • Die Kontrolle bleibt stark konzentriert: 2.000 Series X Aktien bringen 20 Millionen Stimmen (je 10.000 Stimmen), was dem CEO die effektive Kontrolle über zukünftige Unternehmensentscheidungen gibt.
Positive
  • Nasdaq compliance achieved: Stockholder approval satisfies Rules 5635(b)/(d), preserving LRHC’s Capital Market listing.
  • Financing flexibility: Clears path for conversion of $5.5 million note and use of Series B Preferred Stock without triggering default.
  • Enhanced talent incentives: Increasing plan pool to 374,961 shares supports future employee and consultant retention.
Negative
  • Substantial dilution risk: Series B conversion price can fall to $0.082, potentially issuing shares far exceeding 20 % of current float.
  • Insider control: CEO and affiliates hold 97.2 % voting power via super-voting shares, limiting minority influence.
  • Automatic share reserve increases: Equity plan allows annual increases up to 4 % of shares, compounding dilution.
  • Variable pricing feature: Down-round protection lowers conversion price if LRHC issues cheaper securities, pressuring share value.

Insights

TL;DR Approval secures Nasdaq compliance and financing flexibility but sets up material dilution via low-priced preferred conversions.

The written consent clears the final hurdle for LRHC to issue common shares upon conversion of the Series B Preferred Stock tied to the $5.5 million senior secured note. Because the Alternate Conversion Price can reset down to $0.082—well below par—the potential share count expansion is substantial. While this flexibility may strengthen liquidity and honor financing agreements, it comes at the direct cost of current shareholders whose 729,687 outstanding common shares could be diluted many-fold. The 4.99 % individual cap limits single-holder control but does not curb aggregate dilution. Expansion of the equity plan further elevates future supply. On balance, I view the development as negative for equity value but necessary to avert Nasdaq compliance issues.

TL;DR Majority consent highlights extreme insider control; minority holders lack procedural remedies.

Joseph La Rosa controls 97 % of voting power through super-voting preferred shares, enabling unilateral approval. Such concentration, plus the ability to further reprice or reissue options under the incentive plan, weakens traditional shareholder checks. The filing is transparent about the actions but underscores governance risk: minority holders cannot block dilution, lack appraisal rights, and cannot influence compensation-related share issuances. While legal under Nevada law and Nasdaq rules, the structure is shareholder-unfriendly and should command a governance discount.

La Rosa Holdings Corp. (LRHC) ha distribuito una Dichiarazione Informativa Preliminare (Schedule 14C) annunciando che gli azionisti detentori di circa il 97,2% del potere di voto—principalmente il CEO Joseph La Rosa tramite azioni ordinarie e azioni privilegiate Serie X con super voto—hanno fornito il consenso scritto per approvare due importanti azioni societarie:

  • Emissione di “Nuove Azioni di Conversione” oltre la soglia del 19,99% stabilita da Nasdaq. Il consenso soddisfa le regole di quotazione Nasdaq 5635(b) e 5635(d) in relazione all’Accordo di Scambio del 18 giugno 2025, con cui la Società ha scambiato Warrants Incrementali per 6.000 azioni di azioni privilegiate convertibili Serie B. Queste azioni privilegiate si convertono al prezzo minore tra un fisso di $0,25 o un “Prezzo di Conversione Alternativo” variabile (minimo $0,082 e il 95% della media ponderata dei prezzi degli ultimi 7 giorni), con un limite di possesso del 4,99% per singolo azionista. Il capitale del prestito associato al finanziamento precedente è di $5,5 milioni; la conversione completa potrebbe superare il limite del 20% di emissione, da qui la necessità dell’approvazione.
  • Adozione del Secondo Piano Incentivi Azionari Modificato e Rifirmato 2022. Il numero di azioni disponibili aumenta da 156.250 (dopo il raggruppamento azionario 80-per-1) a 374.961 azioni, e la definizione di “Consulente” viene estesa per includere entità legali interamente controllate da individui.

Le azioni diventeranno efficaci 20 giorni dopo la spedizione. Non è richiesta alcuna assemblea né delega. Gli azionisti di minoranza non hanno diritti di dissenso o di valutazione.

Implicazioni per gli investitori:

  • L’approvazione mantiene la conformità alla quotazione Nasdaq e sblocca la struttura di capitale necessaria per convertire le azioni privilegiate Serie B e potenzialmente ridurre il debito.
  • Tuttavia, la conversione a prezzo variabile e il piano incentivi ampliato introducono un significativo rischio di diluizione per gli azionisti ordinari esistenti.
  • Il controllo rimane fortemente concentrato: 2.000 azioni Serie X portano 20 milioni di voti (10.000 voti ciascuna), conferendo al CEO il controllo effettivo sulle decisioni aziendali future.

La Rosa Holdings Corp. (LRHC) ha distribuido una Declaración Informativa Preliminar (Schedule 14C) anunciando que los accionistas que poseen aproximadamente el 97,2% del poder de voto—principalmente el CEO Joseph La Rosa a través de acciones comunes y acciones preferentes Serie X con supervoto—han entregado su consentimiento por escrito para aprobar dos acciones corporativas clave:

  • Emisión de “Nuevas Acciones de Conversión” por encima del umbral del 19,99% establecido por Nasdaq. El consentimiento cumple con las reglas de cotización Nasdaq 5635(b) y 5635(d) en relación con el Acuerdo de Intercambio del 18 de junio de 2025, mediante el cual la Compañía intercambió Warrants Incrementales por 6,000 acciones de acciones preferentes convertibles Serie B. Estas acciones preferentes se convierten al menor entre un precio fijo de $0.25 o un “Precio de Conversión Alternativo” variable (mínimo $0.082 y 95% del VWAP de 7 días), sujeto a un límite de propiedad del 4,99% por titular. El principal del préstamo asociado al financiamiento anterior es de $5.5 millones; la conversión completa podría superar el límite de emisión del 20%, por lo que se requiere aprobación.
  • Adopción del Segundo Plan de Incentivos de Capital Modificado y Reformulado 2022. El grupo de acciones aumenta de 156,250 (después del split inverso 80 por 1) a 374,961 acciones, y la definición de “Consultor” se amplía para incluir entidades legales de propiedad total de individuos.

Las acciones entrarán en vigor 20 días después del envío. No se requiere reunión ni poder. Los accionistas minoritarios no tienen derechos de disenso o tasación.

Implicaciones para los inversores:

  • La aprobación mantiene el cumplimiento de la cotización en Nasdaq y desbloquea la estructura de capital necesaria para convertir las acciones preferentes Serie B y potencialmente reducir la deuda.
  • Sin embargo, la conversión a precio variable y el plan de incentivos ampliado introducen un riesgo significativo de dilución para los accionistas comunes existentes.
  • El control permanece altamente concentrado: 2,000 acciones Serie X otorgan 20 millones de votos (10,000 votos cada una), dando al CEO control efectivo sobre las decisiones corporativas futuras.

La Rosa Holdings Corp. (LRHC)는 예비 정보 성명서(Schedule 14C)를 배포하며 약 97.2%의 의결권을 보유한 주주들—주로 CEO Joseph La Rosa가 보통주와 Series X 슈퍼투표 우선주를 통해—가 두 가지 주요 기업 조치를 승인하는 서면 동의를 제출했다고 발표했습니다:

  • 나스닥의 19.99% 한도를 초과하는 “신규 전환 주식” 발행. 이 동의는 2025년 6월 18일 체결된 교환 계약과 관련하여 나스닥 상장 규칙 5635(b) 및 5635(d)를 충족합니다. 회사는 추가 워런트를 교환하여 6,000주의 Series B 전환 우선주를 받았습니다. 이 우선주는 고정 $0.25 가격 또는 변동 “대체 전환 가격”(최저 $0.082 및 7일 VWAP의 95%) 중 낮은 가격으로 전환되며, 보유자별 4.99% 소유 한도가 적용됩니다. 이전 자금 조달과 관련된 노트 원금은 $550만이며, 완전 전환 시 20% 발행 한도를 초과할 수 있어 승인이 필요합니다.
  • 2022년 2차 수정 및 재작성된 주식 인센티브 계획 채택. 주식 풀은 156,250주(80대 1 액면병합 후)에서 374,961주로 증가하며, “컨설턴트”의 정의가 개인이 전액 소유한 법인까지 확대됩니다.

이 조치들은 발송 후 20일 뒤에 효력이 발생합니다. 주주총회나 위임장은 필요 없습니다. 소수 주주는 반대권이나 감정권이 없습니다.

투자자에 대한 영향:

  • 이번 승인은 나스닥 상장 요건을 유지하고 Series B 우선주 전환과 부채 감축에 필요한 자본 구조를 확보합니다.
  • 그러나 변동 가격 전환과 확대된 인센티브 계획은 기존 보통주 주주에게 상당한 희석 위험을 초래합니다.
  • 지배권은 매우 집중되어 있습니다: 2,000주의 Series X 주식이 2,000만 표(주당 10,000표)를 보유하여 CEO가 향후 기업 결정에 대한 실질적인 통제권을 가집니다.

La Rosa Holdings Corp. (LRHC) a diffusé une déclaration d'information préliminaire (Schedule 14C) annonçant que des actionnaires détenant environ 97,2 % du pouvoir de vote—principalement le PDG Joseph La Rosa via des actions ordinaires et des actions privilégiées Série X avec super droit de vote—ont donné leur consentement écrit pour approuver deux actions clés :

  • Émission de « Nouvelles Actions de Conversion » dépassant le seuil Nasdaq de 19,99 %. Le consentement satisfait aux règles de cotation Nasdaq 5635(b) et 5635(d) en lien avec l’Accord d’Échange du 18 juin 2025, par lequel la société a échangé des bons de souscription supplémentaires contre 6 000 actions privilégiées convertibles de Série B. Ces actions privilégiées se convertissent au moindre entre un prix fixe de 0,25 $ ou un « Prix de Conversion Alternatif » variable (plancher à 0,082 $ et 95 % du VWAP sur 7 jours), avec un plafond de détention de 4,99 % par détenteur. Le principal de la dette liée au financement antérieur est de 5,5 millions de dollars ; une conversion complète pourrait dépasser la limite d’émission de 20 %, d’où la nécessité de l’approbation.
  • Adoption du Plan d’Incentives en Actions 2022, Deuxième Version Amendée et Reformulée. Le nombre d’actions disponibles passe de 156 250 (après un regroupement d’actions 80 pour 1) à 374 961 actions, et la définition de « Consultant » est élargie pour inclure les entités juridiques détenues à 100 % par des individus.

Les actions prennent effet 20 jours après envoi. Aucune assemblée ni procuration n’est requise. Les actionnaires minoritaires n’ont pas de droits de dissidence ou d’expertise.

Implications pour les investisseurs :

  • L’approbation maintient la conformité à la cotation Nasdaq et débloque la structure de capital nécessaire pour convertir les actions privilégiées de Série B et potentiellement réduire la dette.
  • Cependant, la conversion à prix variable et le plan d’incitation élargi introduisent un risque significatif de dilution pour les actionnaires ordinaires existants.
  • Le contrôle reste fortement concentré : 2 000 actions Série X représentent 20 millions de voix (10 000 voix chacune), donnant au PDG un contrôle effectif sur les décisions futures de l’entreprise.

La Rosa Holdings Corp. (LRHC) hat eine vorläufige Informationsmitteilung (Schedule 14C) verteilt, in der angekündigt wird, dass Aktionäre mit ungefähr 97,2 % der Stimmrechte—hauptsächlich CEO Joseph La Rosa über Stammaktien und Series X Super Voting Preferred Stock—schriftlich zugestimmt haben, zwei wichtige Unternehmensmaßnahmen zu genehmigen:

  • Ausgabe von „Neuen Umwandlungsaktien“ über die Nasdaq-Grenze von 19,99 % hinaus. Die Zustimmung erfüllt die Nasdaq-Listenregeln 5635(b) und 5635(d) im Zusammenhang mit der am 18. Juni 2025 geschlossenen Austauschvereinbarung, bei der das Unternehmen zusätzliche Warrants gegen 6.000 Aktien der Series B wandelbaren Vorzugsaktien getauscht hat. Diese Vorzugsaktien wandeln zum niedrigeren Wert von einem festen $0,25 oder einem variablen „Alternativen Umwandlungspreis“ (Mindestpreis $0,082 und 95 % des 7-Tage VWAP) um, mit einer Eigentumsobergrenze von 4,99 % pro Inhaber. Die Anleihekapitalhöhe der früheren Finanzierung beträgt $5,5 Millionen; eine vollständige Umwandlung könnte die 20 % Emissionsgrenze überschreiten, daher die Notwendigkeit der Zustimmung.
  • Verabschiedung des Zweiten Geänderten und Neufassungen des Aktienanreizplans 2022. Der Aktienpool steigt von 156.250 (nach einer 80-zu-1-Aktienzusammenlegung) auf 374.961 Aktien, und die Definition von „Berater“ wird erweitert, um vollständig im Besitz befindliche juristische Personen von Einzelpersonen einzuschließen.

Die Maßnahmen werden 20 Tage nach Versand wirksam. Es ist keine Versammlung oder Vollmacht erforderlich. Minderheitsaktionäre haben keine Widerspruchs- oder Bewertungsrechte.

Auswirkungen für Investoren:

  • Die Zustimmung sichert die Nasdaq-Listing-Compliance und ermöglicht die Kapitalstruktur, die für die Umwandlung der Series B Vorzugsaktien und potenzielle Schuldenreduzierung erforderlich ist.
  • Die variable Umwandlung und der erweiterte Anreizplan bringen jedoch ein erhebliches Verwässerungsrisiko für bestehende Stammaktionäre mit sich.
  • Die Kontrolle bleibt stark konzentriert: 2.000 Series X Aktien bringen 20 Millionen Stimmen (je 10.000 Stimmen), was dem CEO die effektive Kontrolle über zukünftige Unternehmensentscheidungen gibt.
false 0001028918 0001028918 2025-07-11 2025-07-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 11, 2025

 

 

PACIFIC PREMIER BANCORP, INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware   000-22193   33-0743196
(State or other jurisdiction of   (Commission File Number)   (IRS Employer Identification No.)
incorporation)        

 

17901 Von Karman Avenue, Suite 1200, Irvine, CA 92614
(Address of principal executive offices) (zip code)

 

Registrant’s telephone number, including area code: (949) 864-8000

 

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

xWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol   Name of each exchange on which
registered
Common Stock, par value $0.01 per share   PPBI   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 8.01 Other Events.

 

As previously announced, on April 23, 2025, Pacific Premier Bancorp, Inc. (“Pacific Premier”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Columbia Banking System, Inc. (“Columbia”) and Balboa Merger Sub, Inc. (“Merger Sub”), pursuant to which (i) Merger Sub will merge with and into Pacific Premier (the “Merger”), with Pacific Premier surviving the Merger (the “Surviving Corporation”), (ii) immediately following the Merger, the Surviving Corporation will be merged with and into Columbia (the “Second Step Merger”), with Columbia continuing as the surviving entity in the Second Step Merger and (iii) promptly following the Second Step Merger, Pacific Premier Bank, National Association, a national banking association, will merge with and into Umpqua Bank (“Umpqua Bank”), an Oregon state-chartered commercial bank, with Umpqua Bank continuing as the surviving bank (collectively, the “Proposed Transaction”).

 

This Current Report on Form 8-K (this “Form 8-K”) is being filed to supplement the Joint Proxy Statement/Prospectus (the “Joint Proxy Statement/Prospectus”) (1) included in Amendment No. 1 to the Registration Statement on Form S-4, File No. 333-287607 (the “Registration Statement”), filed by Columbia with the U.S. Securities and Exchange Commission (the “SEC”) on June 13, 2025 and declared effective by the SEC on June 16, 2025, (2) filed by Columbia with the SEC as a prospectus on June 16, 2025, (3) filed by Pacific Premier with the SEC as a definitive proxy statement on Schedule 14A on June 16, 2025 and (4) mailed by Pacific Premier and Columbia to their stockholders and shareholders, respectively, commencing on or about June 17, 2025. As of July 11, 2025, (i) one purported holder of Columbia common stock has filed a complaint relating to the Proposed Transaction in the Superior Court of Washington, County of Pierce: Siegel vs. Columbia Banking System, Inc. et al. No. 25-2-09604-7 (filed June 24, 2025) (“Siegel”) and (ii) two purported holders of Pacific Premier common stock have filed complaints relating to the Proposed Transaction in the Supreme Court of the State of New York, County of New York: Clark v. Pacific Premier Bancorp, Inc. et al. No. 653808/2025 (filed June 24, 2025) (“Clark”) and Parshall v. Pacific Premier Bancorp, Inc. et al. No. 653824/2025 (filed June 25, 2025) (“Parshall”). The Siegel complaint names Columbia and its directors as defendants and alleges state law claims of breach of fiduciary duty to disclose material facts in the Joint Proxy Statement/Prospectus and negligent misrepresentation and concealment. Both the Clark and Parshall complaints name Pacific Premier and its directors as defendants and allege state law claims of negligent representation and concealment with respect to allegedly materially incomplete and misleading claims in the Joint Proxy Statement/Prospectus. In addition, each of Pacific Premier and Columbia have received demand letters from purported stockholders of Pacific Premier and shareholders of Columbia, as applicable (collectively, the “Demand Letters”), generally alleging that the Joint Proxy Statement/Prospectus contains material omissions in violation of Section 14(a) and Section 20(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 14a-9 promulgated thereunder. The Siegel, Clark, and Parshall complaints generally seek (i) injunctive relief enjoining the defendants from proceeding with, or closing, (a) the Proposed Transaction or (b) Columbia’s shareholder vote on the issuance of shares of its common stock in connection with the Proposed Transaction (the “Share Issuance”) until the allegedly omitted information is disclosed, (ii) rescinding the Proposed Transaction and the Share Issuance if consummated, or awarding rescissory, actual and punitive damages, (iii) directing the Pacific Premier board of directors and the Columbia board of directors to file a corrected Joint Proxy Statement/Prospectus, and (iv) awarding plaintiffs’ costs, including attorneys’ fees. In addition, the Demand Letters generally demanded supplemental disclosures to remedy alleged deficiencies in the Joint Proxy Statement/Prospectus. Pacific Premier and Columbia may be named in additional similar complaints. If additional complaints are filed against Pacific Premier or Columbia in connection with the Proposed Transaction, absent new or different allegations that are material, Pacific Premier and Columbia will not necessarily announce such additional filings. Pacific Premier and Columbia believe that the claims asserted in the Siegel, Clark, and Parshall complaints, along with those asserted in the Demand Letters, are without merit and specifically deny that any supplemental disclosure was or is required under applicable law. However, in order to moot certain of the plaintiffs’ disclosure claims in the Siegel, Clark, and Parshall complaints and in the Demand Letters, to avoid nuisance, potential expense and delay, and to provide additional information to stockholders of Pacific Premier and shareholders of Columbia, and without admitting any liability or wrongdoing, Pacific Premier and Columbia have determined to voluntarily supplement the Joint Proxy Statement/Prospectus with certain disclosures set forth herein. Pacific Premier, Columbia and the other named defendants deny that they have violated any laws or breached any duties to Pacific Premier’s stockholders or Columbia’s shareholders, as applicable. Nothing in this Form 8-K shall be deemed to be an admission of the legal necessity or materiality under applicable laws of any of the disclosures set forth herein. The information contained in this Form 8-K is incorporated by reference into the Joint Proxy Statement/Prospectus.

 

 

 

 

SUPPLEMENT TO JOINT PROXY STATEMENT/PROSPECTUS

 

The information set forth below supplements the Joint Proxy Statement/Prospectus and should be read in conjunction with the Joint Proxy Statement/Prospectus, which should be read in its entirety. To the extent that information herein differs from or updates information contained in the Joint Proxy Statement/Prospectus, the information contained herein supersedes the information contained in the Joint Proxy Statement/Prospectus. All page references below are to pages in the Joint Proxy Statement/Prospectus, and terms used below shall have the meanings set forth in the Joint Proxy Statement/Prospectus (unless otherwise defined below).

 

The last paragraph on page 57 of the Joint Proxy Statement/Prospectus under the Section “The Mergers—Background of the Mergers” is hereby amended and restated as follows (supplemental disclosure is underlined):

 

On February 19, 2025, the Columbia board of directors held a special meeting at which members of Columbia management and representatives of PSC were present. At the meeting, Mr. Stein informed the Columbia board of directors about his January 30, 2025 and February 11, 2025 conversations with Mr. Gardner. Mr. Stein also noted that, the day prior, the Pacific Premier board of directors had expressed its support for continuing the dialogue exploring the potential transaction. Mr. Stein led the Columbia board of directors in a conversation analyzing the merits of the potential transaction. The Columbia board of directors discussed the benefits and risks associated with the potential transaction, including, other strategic alternatives, the status of the Umpqua merger integration, the extent to which the potential transaction would fit with Columbia’s strategic plan, the combined company’s loan portfolio, the complementary nature of each company’s deposit bases, Columbia’s prior success with acquisitions, and the potential stock market reaction to the potential transaction. In addition, the Columbia board of directors considered the combined company’s potential pro forma loans and deposit base and Columbia’s prior success with mergers and acquisitions. Following this discussion, the Columbia board of directors unanimously expressed its support for continuing to explore the potential transaction with Pacific Premier.

 

The fourth full paragraph on page 58 of the Joint Proxy Statement/Prospectus under the Section “The Mergers—Background of the Mergers” is hereby amended and restated as follows:

 

Also on March 10, 2025, the Columbia board of directors held a special meeting at which members of Columbia management and representatives of PSC were present. At the meeting, representatives of PSC discussed Pacific Premier’s financial position and trends, corporate background and provided a preliminary assessment of the potential transaction, including strategic fit, size, financial impact, timing, areas of risk and potential risk mitigation. The discussion continued and included valuation considerations, such as Pacific Premier’s capital, loan portfolio composition and credit quality, as well as potential cost savings and the potential pro forma ownership split in the combined company following the potential transaction. The Columbia board of directors also discussed the expected impact of the potential transaction on the earnings, growth and the balance sheet mix of the combined company and the expected timeframe to complete integration of the combined company.

 

The last full paragraph on page 58 of the Joint Proxy Statement/Prospectus under the Section “The Mergers—Background of the Mergers” is hereby amended and restated as follows (supplemental disclosure is underlined):

 

On March 19, 2025, the Columbia board of directors held a special meeting at which members of Columbia management and representatives of PSC and Sullivan & Cromwell LLP (“Sullivan & Cromwell”), Columbia’s legal advisor, were present. At the meeting, members of Columbia management discussed with the Columbia board of directors the strategic elements of the transaction, including the ability to significantly accelerate Columbia’s strategic goal of expanding its Southern California presence, the complementary nature of Pacific Premier’s commercial banking strategy and the opportunity for consumer banking growth. Columbia management provided an update on the status of its due diligence of Pacific Premier. Columbia management also discussed the timelines for realizing synergies, systems conversion and integration as well as the compatibility of Pacific Premier’s corporate governance practices, including its board culture, compensation practices and philosophy. Columbia management noted the expected efficiency of expanding into Pacific Premier's footprint through the potential transaction as compared to organic growth and discussed the appeal of Pacific Premier's commercial banking franchise as well as its HOA banking business, custodial trust operations, escrow and 1031 exchange business, and its API banking platform. The Columbia board of directors and Columbia management further discussed Pacific Premier's historical and projected growth trends, financial metrics and overall performance, as well as the opportunities and risks associated with the potential transaction, including impacts on capital levels, loan and deposit compositions, credit profile and profitability, among other factors. At the meeting, the representative of Sullivan & Cromwell advised the Columbia board of directors of their fiduciary duties in reviewing the potential transaction. At the conclusion of the meeting, Mr. Stein stated that based on the status of due diligence, it was Columbia management’s recommendation to move forward with the negotiations toward the potential transaction, with the Columbia board of directors to subsequently approve any proposed final terms of the potential transaction. The Columbia board of directors approved Columbia management moving forward with the potential transaction with Pacific Premier.

 

 

 

 

The first full paragraph on page 61 of the Joint Proxy Statement/Prospectus under the Section “The Mergers—Background of the Mergers” is hereby amended and restated as follows (supplemental disclosure is underlined):

 

Representatives of KBW also updated the Pacific Premier board of directors with respect to discussions the KBW representatives had held in accordance with the Pacific Premier board of directors’ directives with three out of the four other selected potential strategic partners (other than Columbia) that had been identified at the February 18, 2025 meeting of the Pacific Premier board of directors. The KBW representatives reported that three of the other four selected potential strategic partners were contacted following the February 18, 2025 meeting, and while each of those three potential strategic partners acknowledged the quality of Pacific Premier’s franchise, they each provided reasons for why they were not in a position to pursue a potential strategic transaction at this time: Potential Strategic Partner A cited an uncertain economic environment and an uncertain regulatory environment for larger bank strategic transactions; Potential Strategic Partner B cited the timing and status of integration efforts related to a recent acquisition; and Potential Strategic Partner C indicated that it would not entertain an all-stock transaction given the then-current valuation of its stock as a result of prevailing market volatility. One of the other selected potential strategic partners was not contacted because it appeared that it was no longer a viable potential strategic partner. During this process, no potential strategic partner other than Columbia entered into a confidentiality agreement with Pacific Premier. The Pacific Premier board of directors considered these responses as the board continued to weigh the strategic and financial attributes of what appeared to be an actionable potential strategic transaction with Columbia, on the one hand, and the prospects of Pacific Premier continuing on a stand-alone basis and exploring a potential strategic transaction in the future, once market volatility subsided and the economic and regulatory outlook became clearer. Following these discussions, the Pacific Premier board of directors directed Pacific Premier management and Pacific Premier’s advisors to continue negotiations with Columbia regarding the terms of the transaction (including the exchange ratio and pro forma ownership split), and the transaction documentation, while at the same time continuing to analyze Pacific Premier’s prospects on a stand-alone basis.

 

The second full paragraph on page 62 of the Joint Proxy Statement/Prospectus under the Section “The Mergers—Background of the Mergers” is hereby amended and restated as follows (supplemental disclosure is underlined):

 

On April 22, 2025, as part of its regularly scheduled quarterly meetings, the Columbia board of directors held an information session with Columbia management and representatives of PSC and Sullivan & Cromwell in attendance. At the meeting, representatives of PSC provided an overview of various aspects of the potential transaction from a financial perspective based on the exchange ratio that had been preliminarily agreed with Pacific Premier, including the anticipated impact of the potential transaction on certain key metrics, including earnings per share, tangible book value per share, and the related earn-back periods, as well as the pro forma capital levels of Columbia following the potential transaction. Columbia management reviewed key model assumptions, including purchase accounting marks, interest rate risk and expected capital ratios for the combined company. Columbia management also reviewed the projected pro forma closing balance sheet and income statement. Representatives of Sullivan & Cromwell then provided an overview of the current drafts of the transaction documents including the merger agreement and outlined various matters related to the legal and regulatory process. There was then a further discussion of the strategic and financial rationale for the proposed transaction, including, among other considerations discussed above, Pacific Premier Bank’s branch density and the number of businesses located within its footprint. The Columbia board of directors remained supportive of moving forward with the potential transaction.

 

 

 

 

The disclosure under the heading “The Mergers—Opinion of Columbia’s Financial Advisor—Comparable Company Analyses” is hereby amended by deleting the table of company names at the bottom of page 74 (the Columbia Peer Group) of the Joint Proxy Statement/Prospectus and replacing it with the following:

 

Financials as of December 31, 2024  Balance Sheet  Capital Position  LTM Profitability  Valuation as
of April 22, 2025
 
                                    Price /        
      Loans /  NPAs /  TCE /  Lev.  Total
RBC
  CRE /
Total
  Core  Core
ROA-
     Effic.     Core
LTM
  2025E  2026E  Div.  Mkt.  
   Assets  Deps.  Assets  TA  Ratio  Ratio  RBC¹  ROAA²  TCE²  NIM  Ratio  TBV  EPS²  EPS  EPS  Yield  Cap  
Company  ($M)  (%)  (%)  (%)  (%)  (%)  (%)  (%)  (%)  (%)  (%)  (%)  (x)  (x)  (x)  (%)  ($M)  
Zions Bancorporation, National Association³  87,992  79.2  0.35  5.94  8.40  13.30  163  0.87  15.5  3.04  64.3  123  8.7  8.2  7.7  3.9  6,365  
Western Alliance Bancorporation³  83,043  79.0  0.60  7.25  8.60  14.50  219  0.94  13.3  3.54  63.8  121  9.4  7.5  6.3  2.3  7,126  
First Horizon Corporation³  81,491  96.9  1.12⁴  8.37  10.49  13.68  174  1.12  13.1  3.35  59.5  130  10.6  10.1  9.1  3.6  8,660  
Webster Financial Corporation  79,025  81.1  0.58  7.45  8.70  14.24  262  1.21  16.7  3.42  46.1  140  8.7  7.9  7.1  3.6  7,909  
Comerica Incorporated³  77,622  81.2  0.39  7.82  11.36  14.39  124  0.94  13.0  3.09  69.2  112  9.5  10.1  9.0  5.6  6,749  
East West Bancorp, Inc.³  76,165  86.0  0.24  9.86  10.46  15.63  230  1.58  16.5  3.27  36.3  146  9.5  9.2  8.4  3.1  10,966  
Popular, Inc.  73,045  57.2  0.56  6.62  8.66  17.83  79  0.83  9.8  3.49  61.1  131  10.5  9.0  7.7  3.3  6,204  
Wintrust Financial Corporation³  65,870  90.9  0.26  8.12  9.60  12.50  227⁵  1.16  14.2  3.52  56.5  135  10.3  10.1  9.6  2.0  7,138  
Valley National Bancorp  62,492  97.5  0.60  8.43  9.16  13.87  372  0.65  8.3  2.85  57.6  92  11.4  8.9  7.2  5.4  4,693  
Synovus Financial Corp.³  60,339  83.9  0.63⁴  7.26  9.56  13.65  249  1.29  17.3  3.23  53.4  133  8.3  8.2  7.7  3.9  5,786  
Pinnacle Financial Partners, Inc.³  54,255  81.2  0.32  8.51  9.50  13.00  235  1.14  13.2  3.19  54.7  169  13.4  12.5  11.1  1.0  7,435  
Old National Bancorp³  53,878  88.7  0.88  7.76  9.44  13.68  250  1.16  16.3  3.31  52.6  159  10.5  9.5  7.6  2.9  6,364  
Cullen/Frost Bankers, Inc.  52,520  48.6  0.18  5.89  8.63  15.53  129  1.20  19.8  3.65  60.0  238  12.5  12.6  12.6  3.4  7,288  
BOK Financial Corporation³  50,472  61.9  0.16  9.48  10.02  14.54  141  1.04  12.2  2.70  65.9  121  10.7  10.7  9.6  2.5  5,664  
UMB Financial Corporation  50,410  59.4  0.09  6.37  8.50  13.21  195  1.04  14.6  2.51  61.0  144  10.3  10.0  8.5  1.8  6,838  
F.N.B. Corporation³  49,020  91.9  0.33  8.37  8.72  12.35⁴  194  1.10  14.1  3.05  56.2  119  9.1  9.2  7.8  3.9  4,643  
Cadence Bank³  47,743  84.4  0.34  8.87  10.60  14.10  191  1.15  13.6  3.35  56.7  125  9.7  9.9  8.9  4.0  5,135  
SouthState Corporation  46,381  89.1  0.45  8.79  10.04  14.96  220  1.25  15.5  3.43  55.6  170  11.7  11.2  9.3  2.6  8,820  
Associated Banc-Corp  43,023  85.9  0.34  7.82  8.73  12.61  212  0.87  11.8  2.78  59.6  106  9.2  8.5  7.8  4.6  3,410  
Prosperity Bancshares, Inc.  39,567  78.0  0.20  10.75  10.82  17.67  161  1.24  13.0  2.93  46.2  165  13.0  11.6  10.4  3.5  6,398  
Bank OZK³  39,165  96.5⁴  0.53⁴  12.55  13.85  14.42  344  1.90  15.2  4.45  33.8  97  6.8  6.8  6.3  4.3  4,706  
BankUnited, Inc.  35,242  87.2  0.63  7.78  8.48  14.09  170  0.67  8.8  2.73  62.0  87  10.2  9.8  8.9  4.0  2,382  

 

 

1)Reflects bank-level financials as of December 31, 2024
2)Core calculated as earnings before extraordinary items less income attributable to noncontrolling interest, gain on sale of securities, amortization of intangibles, goodwill or other non-recurring items, as defined by S&P Capital IQ Pro
3)Financials as of March 31, 2025
4)Regulatory holding company financials as of December 31, 2024
5)Represents CRE / Total RBC as of December, for Wintrust Bank, National Association, Wintrust Financial Corporation’s largest bank subsidiary

 

 

 

 

The disclosure under the heading “The Mergers—Opinion of Columbia’s Financial Advisor—Comparable Company Analyses” is hereby amended by deleting the table of company names at the top of page 76 (the Pacific Premier Peer Group) of the Joint Proxy Statement/Prospectus and replacing it with the following:

 

Financials as of December 31, 2024  Balance Sheet  Capital Position  LTM Profitability  Valuation as of April 22, 2025  
                                    Price /        
      Loans /  NPAs /  TCE /  Lev.  Total
RBC
  CRE /
Total
  Core  Core
ROA-
     Effic.     Core LTM  2025E  2026E  Div.  Mkt.  
   Assets  Deps.  Assets  TA  Ratio  Ratio  RBC¹  ROAA²  TCE²  NIM  Ratio  TBV  EPS²  EPS  EPS  Yield  Cap  
Company  ($M)  (%)  (%)  (%)  (%)  (%)  (%)  (%)  (%)  (%)  (%)  (%)  (x)  (x)  (x)  (%)  ($M)  
Banc of California, Inc.  33,543  87.5  0.59  7.99  10.15  17.05  288  0.53  5.8  2.85  72.6  85  15.1  11.0  8.2  3.1  2,256  
First Interstate BancSystem, Inc.  29,137  77.5  0.49  7.55  8.71  14.38  276  0.79  11.5  3.04  61.2  133  11.6  11.0  10.0  7.2  2,768  
Glacier Bancorp, Inc.  27,903  84.0  0.07  7.92  8.93  14.49  261  0.73  9.8  2.77  66.0  217  22.5  17.9  13.4  3.4  4,606  
WaFd, Inc.³  27,645  98.6  0.26  8.40  9.16⁴  14.43⁴  361  0.86  10.1  2.53  57.0  100  10.2  10.2  --  3.9  2,297  
Bank of Hawaii Corporation³  23,885  67.2  0.07  5.61  8.36  14.97  193  0.70  11.5  2.21  65.3  199  18.0  15.1  13.1  4.3  2,658  
First Hawaiian, Inc.  23,828  70.9  0.09  7.10  9.14  13.99  194  1.06  16.3  2.95  59.2  182  11.8  11.8  11.1  4.6  2,939  
Axos Financial, Inc.  23,709  99.1  1.06  10.12  10.02  15.23  319  1.93  20.8  4.88  45.1  146  7.9  8.4  7.7  0.0  3,482  
Cathay General Bancorp³  23,205  97.6  0.75  10.89  11.06  15.19  281  1.24  11.7  3.08  48.5  117  10.3  9.4  8.5  3.5  2,899  
Hope Bancorp, Inc.³  17,068  92.0  0.49  10.20  11.92  15.06  277  0.58  6.0  2.54  67.7  69  11.8  11.0  7.8  5.9  1,176  
Banner Corporation³  16,171  84.2  0.26  9.23  11.22  15.23  255  1.13  13.2  3.78  61.6  145  11.9  11.4  10.7  3.2  2,114  
CVB Financial Corp.  15,154  71.4  0.31  9.81  11.46  17.06  236  1.29  15.2  3.09  45.1  182  12.4  13.1  12.1  4.5  2,561  

  

 

1)Reflects bank-level financials as of December 31, 2024
2)Core calculated as earnings before extraordinary items less income attributable to noncontrolling interest, gain on sale of securities, amortization of intangibles, goodwill or other non-recurring items, as defined by S&P Capital IQ Pro
3)Financials as of March 31, 2025
4)Regulatory holding company financials as of December 31, 2024

 

 

 

 

The disclosure under the heading “The Mergers—Opinion of Columbia’s Financial Advisor—Analysis of Precedent Transactions” is hereby amended by deleting the table of Acquiror and Target names at the top of page 77 (the Precedent Transactions) of the Joint Proxy Statement/Prospectus and replacing it with the following:

 

         Transaction Information  Target Information  
            Price /  Pay-  Core  1-Day              LTM     
         Deal  LTM     To-  Dep.  Mkt.  Total  TCE /  LTM  LTM  Effic.  NPAs /  
         Value  EPS  TBV  Trade  Prem.  Prem.  Assets  TA  ROAA  ROAE  Ratio  Assets  
Acquiror  Target  Annc. Date  ($M)  (x)  (%)  (%)  (%)  (%)  ($M)  (%)  (%)  (%)  (%)  (%)  
Old National Bancorp  Bremer Financial Corporation  11/25/24  1,401  13.4  100  55  (0.0)  --  16,209  8.71  0.63  7.3  68.4  0.41  
Atlantic Union Bankshares Corporation  Sandy Spring Bancorp, Inc.  10/21/24  1,600  18.4  128  58  3.8  7.1  14,383  8.83  0.61  5.4  67.5  0.89  
SouthState Corporation  Independent Bank Group, Inc.  05/20/24  2,021  19.2  148  85  4.9  10.4  18,871  7.62  0.56  4.4  66.2  0.34  
UMB Financial Corporation  Heartland Financial USA, Inc.  04/29/24  1,990  27.6  153  107  5.2  28.1  19,133  6.88  0.40  4.2  60.7  0.46  
Provident Financial Services, Inc.  Lakeland Bancorp, Inc.  09/27/22  1,263  12.4  154  114  5.7  18.3  10,374  8.01  0.97  9.4  54.0  0.24  

 

 

 

 

The disclosure under the heading “The Mergers—Opinion of Columbia’s Financial Advisor—Net Present Value Analyses” is hereby supplemented by adding the following to the first paragraph thereunder as a new third sentence following the number 165% at the bottom of page 77 of the Joint Proxy Statement/Prospectus:

 

PSC selected these price to earnings and tangible book value multiples based on PSC’s review of, among other matters, the trading multiples of selected companies that PSC deemed to be comparable to Columbia.

 

The disclosure under the heading “The Mergers—Opinion of Columbia’s Financial Advisor—Net Present Value Analyses” is hereby supplemented by adding the following table after the Earnings Per Share Multiples chart (Annual Estimate Variance) in the middle of page 78 of the Joint Proxy Statement/Prospectus:

 

The following table describes the discount rate calculation for Columbia common stock prepared by PSC. In its normal course of business, PSC employs the Kroll Cost of Capital Navigator in determining an appropriate discount rate. The discount rate for Columbia common stock equals the sum of the risk-free rate plus the product of the 2-year beta for Columbia common stock and the equity risk premium, plus the size premium.

 

Calculation of Columbia Discount Rate    
Risk-free rate   4.94%
Equity risk premium   5.00%
Size premium   0.52%
2-year beta   112.1%
Calculated discount rate   11.07%

 

The disclosure under the heading “The Mergers—Opinion of Columbia’s Financial Advisor—Net Present Value Analyses” is hereby supplemented by adding the following to the paragraph at the bottom of page 78 of the Joint Proxy Statement/Prospectus as a new third sentence following the number 165%:

 

PSC selected these price to earnings and tangible book value multiples based on PSC’s review of, among other matters, the trading multiples of selected companies that PSC deemed to be comparable to Pacific Premier.

 

The disclosure under the heading “The Mergers—Opinion of Columbia’s Financial Advisor—Net Present Value Analyses” is hereby supplemented by adding the following table after the Earnings Per Share Multiples chart (Annual Estimate Variance) in the middle of page 79 of the Joint Proxy Statement/Prospectus:

 

The following table describes the discount rate calculation for Pacific Premier common stock prepared by PSC. In its normal course of business, PSC employs the Kroll Cost of Capital Navigator in determining an appropriate discount rate. The discount rate for Pacific Premier common stock equals the sum of the risk-free rate plus the product of the 2-year beta for Pacific Premier common stock and the equity risk premium, plus the size premium.

 

Calculation of Pacific Premier Discount Rate    
Risk-free rate   4.94%
Equity risk premium   5.00%
Size premium   1.02%
2-year beta   112.2%
Calculated discount rate   11.57%

 

 

 

 

The disclosure under the heading “The Mergers—Opinion of Columbia’s Financial Advisor—Pro Forma Transaction Analysis” is hereby supplemented by adding the following to the first paragraph thereunder as a new third sentence at the top of page 80 of the Joint Proxy Statement/Prospectus:

 

For more information about certain of the assumptions provided by the senior management of Columbia for use in PSC’s pro forma analysis, see slide 18 of the Investor Presentation furnished by Columbia as an exhibit to its Current Report on Form 8-K filed with the SEC on April 23, 2025, which slide 18 is incorporated by reference herein.

 

The disclosure under the heading “The Mergers—Opinion of Columbia’s Financial Advisor—Pro Forma Transaction Analysis” is hereby supplemented by adding the following table directly following the first paragraph thereunder at the top of page 80 of the Joint Proxy Statement/Prospectus:

 

The following table describes estimated earnings per share and tangible book value accretion and dilution metrics for Columbia as indicated in the analysis:

 

    

Closing

12/31/2025

    2026E    2027E    2028E 
EPS Accretion/(Dilution)        13.5%   14.7%   13.5%
TBV Accretion / (Dilution)   (7.6)%   (4.5)%   (2.1)%   (0.0)%

 

The disclosure on page 89 of the Joint Proxy Statement/Prospectus under the section “The Mergers—Opinion of Pacific Premier’s Financial Advisor” is hereby supplemented by amending and restating the table of selected transactions as follows:

 

Acquiror  Acquired Company  Announcement Date
Berkshire Hills Bancorp, Inc.  Brookline Bancorp, Inc.  12/16/2024
Old National Bancorp  Bremer Financial Corporation  11/25/2024
Atlantic Union Bankshares Corporation  Sandy Spring Bancorp, Inc.  10/21/2024
Renasant Corporation  The First Bancshares, Inc.  7/29/2024
SouthState Corporation  Independent Bank Group, Inc.  5/20/2024
UMB Financial Corporation  Heartland Financial USA, Inc.  4/29/2024
Provident Financial Services, Inc.  Lakeland Bancorp, Inc.  9/27/2022
Raymond James Financial, Inc.  TriState Capital Holdings, Inc.  10/20/2021
Valley National Bancorp  Bank Leumi Le-Israel Corporation  9/23/2021
First Interstate BancSystem, Inc.  Great Western Bancorp, Inc.  9/16/2021
Citizens Financial Group, Inc.  Investors Bancorp, Inc.  7/28/2021
Old National Bancorp  First Midwest Bancorp, Inc.  6/1/2021
New York Community Bancorp, Inc.  Flagstar Bancorp, Inc.  4/26/2021
Independent Bank Corp.  Meridian Bancorp, Inc.  4/22/2021
BancorpSouth Bank  Cadence Bancorporation  4/12/2021

 

The disclosure on page 90 of the Joint Proxy Statement/Prospectus under the section “The Mergers—Opinion of Pacific Premier’s Financial Advisor” is hereby supplemented by adding the following paragraph below the bottom table:

 

The low and high price-to-tangible book value multiples of the selected transactions in the “Selected Transactions Analysis” were 1.00x and 1.84x, respectively, the low and high pay-to-trade ratios of the selected transactions were 0.55x and 1.19x, respectively, the low and high price-to-LTM Core EPS of the selected transactions were 3.9x and 20.3x, respectively, the low and high price-to-FWD EPS of the selected transactions were 9.3x and 15.6x, respectively, and the low and high core deposit premiums of the selected transactions were 0.0% and 8.7%, respectively. For the 13 selected transactions in which the acquired company was publicly traded, the low and high one-day market premiums of the selected transactions were 1.0% and 28.9%, respectively.

 

 

 

 

The disclosure on page 91 of the Joint Proxy Statement/Prospectus under the section “The Mergers—Opinion of Pacific Premier’s Financial Advisor” is hereby supplemented by amending and restating the second and third to last sentences of the last full paragraph as follows:

 

This analysis indicated the mergers could be accretive to Columbia’s estimated 2026 EPS and 2027 EPS by 14.1% and 15.2%, respectively, and could be dilutive to Columbia’s estimated tangible book value per share at closing, assumed as of December 31, 2025, by 7.4%. The analysis also indicated that, based on Columbia’s projected pro forma financial results attributable to a share of Pacific Premier common stock using the 0.9150 exchange ratio provided for in the merger agreement, the mergers could be accretive relative to Pacific Premier’s estimated 2026 EPS and estimated 2027 EPS by 84.1% and 66.5%, respectively, and could be dilutive relative to Pacific Premier’s estimated tangible book value per share at closing assumed as of December 31, 2025, by 23.2%.

 

The disclosure on pages 92 and 93 of the Joint Proxy Statement/Prospectus under the section “The Mergers—Opinion of Pacific Premier’s Financial Advisor” is hereby supplemented by adding the following sentence between the first and second sentence in the paragraph beginning on page 92 and ending on page 93:

 

The range of discount rates of 12.5% to 14.5% assumed in each of the “Pacific Premier Dividend Discount Model Analysis,” the “Columbia Dividend Discount Model Analysis” and the “Illustrative Pro Forma Combined Dividend Discount Model Analysis” were selected by taking into account capital asset pricing model implied cost of capital calculations.

 

The disclosure on pages 93 of the Joint Proxy Statement/Prospectus under the section “The Mergers—Opinion of PPBI’s Financial Advisor” is hereby supplemented by amending and restating the first sentence of the second full paragraph on page 93 as follows:

 

Pursuant to the KBW engagement agreement, Pacific Premier agreed to pay KBW a cash fee equal to 1.10% of the aggregate merger consideration, which is currently estimated to be approximately $22.5 million, $2,000,000 of which became payable to KBW with the rendering of KBW’s opinion (regardless of the conclusion reached in KBW’s opinion) and the balance of which is contingent upon the closing of the merger.

 

FORWARD-LOOKING STATEMENTS

 

This communication may contain certain forward-looking statements, including, but not limited to, certain plans, expectations, goals, projections, and statements about the benefits of the proposed business combination transaction between Columbia and Pacific Premier, the plans, objectives, expectations and intentions of Columbia and Pacific Premier, the expected timing of completion of the Proposed Transaction, and other statements that are not historical facts. Such statements are subject to numerous assumptions, risks, and uncertainties. All statements other than statements of historical fact, including statements about beliefs and expectations, are forward-looking statements. Forward-looking statements may be identified by words such as “expect,” “anticipate,” “believe,” “intend,” “estimate,” “plan,” “believe,” “target,” “goal,” or similar expressions, or future or conditional verbs such as “will,” “may,” “might,” “should,” “would,” “could,” or similar variations. The forward-looking statements are intended to be subject to the safe harbor provided by Section 27A of the Securities Act of 1933, Section 21E of the Exchange Act, and the Private Securities Litigation Reform Act of 1995.

 

 

 

 

Although there is no assurance that any list of risks and uncertainties or risk factors is complete, below are certain factors which could cause actual results to differ materially from those contained or implied in the forward-looking statements or historical performance: changes in general economic, political, or industry conditions, and in conditions impacting the banking industry specifically; uncertainty in U.S. fiscal, monetary and trade policy, including the interest rate policies of the Federal Reserve Board or the effects of any declines in housing and commercial real estate prices, high or increasing unemployment rates, continued or renewed inflation, the impact of proposed or imposed tariffs by the U.S. government or retaliatory tariffs proposed or imposed by U.S. trading partners that could have an adverse impact on customers or any recession or slowdown in economic growth particularly in the western United States; volatility and disruptions in global capital and credit markets; the impact of bank failures or adverse developments at other banks on general investor sentiment regarding the stability and liquidity of banks; changes in interest rates that could significantly reduce net interest income and negatively affect asset yields and valuations and funding sources, including impacts on prepayment speeds; competitive pressures among financial institutions and nontraditional providers of financial services, including on product pricing and services; concentrations within Columbia’s or Pacific Premier’s loan portfolio (including commercial real estate loans), large loans to certain borrowers, and large deposits from certain clients; the success, impact, and timing of Columbia’s and Pacific Premier’s respective business strategies, including market acceptance of any new products or services and Columbia’s and Pacific Premier’s ability to successfully implement efficiency and operational excellence initiatives; the nature, extent, timing, and results of governmental actions, examinations, reviews, reforms, regulations, and interpretations; changes in laws or regulations; the occurrence of any event, change or other circumstances that could give rise to the right of one or both of the parties to terminate the merger agreement to which Columbia and Pacific Premier are parties; the outcome of any legal proceedings that may be instituted against Columbia or Pacific Premier; delays in completing the Proposed Transaction; the failure to obtain necessary regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the Proposed Transaction); the failure to obtain shareholder or stockholder approvals, as applicable, or to satisfy any of the other conditions to the closing of the Proposed Transaction on a timely basis or at all; changes in Columbia’s or Pacific Premier’s share price before closing, including as a result of the financial performance of the other party prior to closing, or more generally due to broader stock market movements, and the performance of financial companies and peer group companies; the possibility that the anticipated benefits of the Proposed Transaction are not realized when expected or at all, including as a result of the impact of, or problems arising from, the integration of the two companies or as a result of the strength of the economy and competitive factors in the areas where Columbia and Pacific Premier do business; certain restrictions during the pendency of the Proposed Transaction that may impact the parties’ ability to pursue certain business opportunities or strategic transactions; the possibility that the Proposed Transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; diversion of management’s attention from ongoing business operations and opportunities; potential adverse reactions or changes to business or employee relationships, including those resulting from the announcement or completion of the Proposed Transaction; the ability to complete the Proposed Transaction and integration of Columbia and Pacific Premier promptly and successfully; the dilution caused by Columbia’s issuance of additional shares of its capital stock in connection with the Proposed Transaction; and other factors that may affect the future results of Columbia and Pacific Premier. Additional factors that could cause results to differ materially from those described above can be found in Columbia’s Registration Statement on Form S-4, its Annual Report on Form 10-K for the year ended December 31, 2024 and its Quarterly Report on Form 10-Q for the three-month period ended March 31, 2025, which are on file with the SEC and available on Columbia’s investor relations website, www.columbiabankingsystem.com, under the heading “SEC Filings,” and in other documents Columbia files with the SEC, and in Pacific Premier’s Annual Report on Form 10-K for the year ended December 31, 2024 and its Quarterly Report on Form 10-Q for the three-month period ended March 31, 2025, which are on file with the SEC and available on Pacific Premier’s website, www.investors.ppbi.com, under the heading “SEC Filings” and in other documents Pacific Premier files with the SEC.

 

All forward-looking statements speak only as of the date they are made and are based on information available at that time. Neither Columbia nor Pacific Premier assumes any obligation to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements were made or to reflect the occurrence of unanticipated events except as required by federal securities laws. As forward-looking statements involve significant risks and uncertainties, caution should be exercised against placing undue reliance on such statements.

 

 

 

 

IMPORTANT ADDITIONAL INFORMATION AND WHERE TO FIND IT

 

In connection with the Proposed Transaction, Columbia filed with the SEC a Registration Statement on Form S-4 that includes a Joint Proxy Statement of Columbia and Pacific Premier and a Prospectus of Columbia, which the SEC declared effective June 16, 2025. Columbia and Pacific Premier commenced mailing of the definitive Joint Proxy Statement/Prospectus to Columbia’s shareholders and Pacific Premier’s stockholders seeking certain approvals related to the Proposed Transaction on or about June 17, 2025. Columbia and Pacific Premier may also file other relevant documents concerning the Proposed Transaction with the SEC. This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. INVESTORS, COLUMBIA SHAREHOLDERS AND PACIFIC PREMIER STOCKHOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT AS WELL AS THE JOINT PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION, AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION. Shareholders or stockholders, as applicable, can obtain a free copy of the definitive Joint Proxy Statement/Prospectus, as well as other filings containing information about the Proposed Transaction, Columbia and Pacific Premier, without charge, at the SEC’s website, www.sec.gov. Copies of these documents and the filings with the SEC incorporated by reference in these documents can also be obtained, without charge, by directing a request to Columbia Banking System, Inc., Attention: Investor Relations, 1301 A Street, Tacoma, WA 98402-4200, (503) 727-4100 or to Pacific Premier Bancorp, Inc., Attention: Corporate Secretary, 17901 Von Karman Avenue, Suite 1200, Irvine, CA 92614, (949) 864-8000.

 

PARTICIPANTS IN THE SOLICITATION

 

Columbia, Pacific Premier, and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from Columbia shareholders or Pacific Premier stockholders in connection with the Proposed Transaction under the rules of the SEC. Information regarding Columbia’s directors and executive officers is available in the sections entitled “Directors, Executive Officers and Corporate Governance” and “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” in Columbia’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which was filed with the SEC on February 25, 2025 (available here); in the sections entitled “Board Structure and Compensation,” “Compensation Discussion and Analysis,” “Compensation Tables,” “Information about Executive Officers,” “Beneficial Ownership of Directors and Executive Officers” and “Certain Relationships and Related Transactions” in Columbia’s definitive proxy statement relating to its 2025 Annual Meeting of Shareholders, which was filed with the SEC on April 3, 2025 (available here); and other documents filed by Columbia with the SEC. Information regarding Pacific Premier’s directors and executive officers is available in the sections entitled “Directors, Executive Officers and Corporate Governance” and “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” in Pacific Premier’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which was filed with the SEC on February 28, 2025 (available here); in the sections entitled “Compensation of Non-Employee Directors,” “Security Ownership of Directors and Executive Officers,” “Certain Relationships and Related Transactions,” “Summary Compensation Table,” “Employment Agreements, Salary Continuation Plans, Severance, and Change-in-Control Payments,” and “Summary of Potential Termination Payments” in Pacific Premier’s definitive proxy statement relating to its 2025 Annual Meeting of Stockholders, which was filed with the SEC on April 7, 2025 (available here); and other documents filed by Pacific Premier with the SEC. To the extent holdings of Columbia common stock by the directors and executive officers of Columbia or holdings of Pacific Premier common stock by directors and executive officers of Pacific Premier have changed from the amounts held by such persons as reflected in the documents described above, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with the SEC. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, is contained in the Joint Proxy Statement/Prospectus relating to the Proposed Transaction. Free copies of this document may be obtained as described in the preceding paragraph.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PACIFIC PREMIER BANCORP, INC.
     
  By:

/s/ Steven R. Gardner

  Name: Steven R. Gardner
  Title: Chairman, Chief Executive Officer and President

 

Dated: July 11, 2025  

 

 

 

FAQ

Why did La Rosa Holdings (LRHC) need stockholder approval for the Series B Preferred Stock conversion?

Because full conversion could exceed 19.99 % of outstanding common shares, Nasdaq Listing Rules 5635(b)/(d) required prior stockholder consent to maintain listing compliance.

What is the lowest possible conversion price for LRHC’s Series B Preferred Stock?

The Certificate of Designation sets a floor price of $0.082 per share, subject to a 95 % of 7-day VWAP calculation.

How many shares can now be granted under LRHC’s equity incentive plan?

The Second Amended 2022 Plan increases the maximum pool to 374,961 shares, from 156,250 previously.

When will the approved corporate actions become effective?

They take effect 20 calendar days after the Information Statement is first mailed to stockholders.

Do minority LRHC stockholders have dissenter or appraisal rights for these actions?

No. The Information Statement explicitly states that dissenter’s rights do not apply to these approvals.

What voting power does CEO Joseph La Rosa hold?

He controls 2,000 Series X Super Voting Preferred Shares (10,000 votes each) plus common stock, totaling 97.2 % of outstanding voting power.
Pacific Premier Bancorp

NASDAQ:PPBI

PPBI Rankings

PPBI Latest News

PPBI Stock Data

2.24B
94.83M
1.9%
97.07%
1.58%
Banks - Regional
State Commercial Banks
Link
United States
IRVINE